Shanghai Pharmaceuticals Holding Co. Ltd.

Shanghai Pharmaceuticals Holding Co. Ltd. (“SPH”) is a vertically-integrated and diversified pharmaceutical group. The company has dual listings on the stock exchanges in Shanghai (601607) and Hong Kong (02067) respectively. The company provides leading healthcare services in: Research & Development, Manufacturing, Distribution and Retail.  

In 2017, SPH reported revenues of US$20.5bn, making the company one of the country’s major forces in the industry. SPH is one of the few listed pharmaceutical companies with a leading position in both manufacturing and distribution in China. SHP is the 133th of TOP 500 China Companies. In 2017 China Top 100 Pharmaceutical Industry Enterprises list ranked #6